Peptide questions · Ecnoglutide
How long does ecnoglutide take to work?
Reviewed Evidence: EstablishedPublished by PepVault
Ecnoglutide’s onset is days–2 weeks, its peak effect comes at 48 weeks (phase 3, no plateau), and its typical duration is ongoing, by the library’s timeline (backed by clinical trial data).
The timeline’s basis: Phase 3 SLIMMER (Ji 2025, Lancet Diabetes Endocrinol), phase 3 in type 2 diabetes (Zhu 2026, Nat Commun; He 2025, Lancet Diabetes Endocrinol), approvals (Shirley 2026, Drugs), Sciwind release Mar-6-2026, interaction studies (Chen 2026; Li 2026). The Chinese label was not read.
Ecnoglutide week by week
The library places six of its research notes on ecnoglutide on the days they cover, from day 1 to day 336 and on: 5 on randomized trials and 1 on clinical data.
Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.
| When | The note | Evidence |
|---|---|---|
| Days 1–28 (weeks 1–4) | A low first month | Randomized trial |
| Days 29–56 (weeks 5–8) | Doubling to 0.6 mg | Randomized trial |
| Days 57–336 (weeks 9–48) | The lowest weight-loss dose | Randomized trial |
| Days 85–336 (weeks 13–48) | The middle dose | Randomized trial |
| Days 85–336 (weeks 13–48) | The top dose | Randomized trial |
| From day 337 on | A long-term medicine, not a course | Clinical data |

Model. Individual results vary.
The ecnoglutide timeline’s milestones
The library’s timeline for ecnoglutide marks 5 points from week 1 to week 48, backed by clinical trial data overall.
- Week 1: Commonly reported: appetite dropping in the first days on 0.3 mg
- Week 4: The diabetes trials doubled the dose to 0.6 mg at week 4
- Week 8: And to 1.2 mg at week 8
- Week 40: SLIMMER endpoint: about 9% (1.2 mg) to 13% (2.4 mg) average loss vs about 0% on placebo
- Week 48: Sciwind: about 15% average loss at 2.4 mg, still falling
The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.
Why ecnoglutide takes that long
Ecnoglutide’s half-life is about 5.5 days (132 hours), so one dose is about 96.9% cleared after 28 days.
On its schedule (Weekly) the doses overlap, and the level of ecnoglutide keeps climbing for about 22–28 days before it levels off, so the first 22–28 days run below the level the later weeks hold.
The notes on ecnoglutide follow the trials’ dose steps, 0.3mg, 0.6mg, 1.2mg, 1.8mg and 2.4mg, so the later weeks also describe higher steps than the first ones; these are steps from studies, not a schedule for a person.
Ecnoglutide against other metabolic & GLP-1 compounds
The library holds an onset-and-peak timeline for 21 metabolic & GLP-1 compounds, ecnoglutide among them; 15 of the others share its onset of days–2 weeks.
| Compound | Onset | Peak effect |
|---|---|---|
| Semaglutide | Days–2 weeks | 60–68 weeks |
| Tirzepatide | Days–2 weeks | 72+ weeks |
| Retatrutide | Days–2 weeks | 48+ weeks |
| Dulaglutide | Days–2 weeks | 24–52 weeks (glucose) |
| Exenatide | First dose (after-meal glucose) | 24–30 weeks (HbA1c) |
| Setmelanotide | 1–2 weeks (hunger) | 52 weeks (BMI) |
| Orforglipron | Days–2 weeks | 72 weeks (trial endpoint) |
| Survodutide | Days–2 weeks | 76 weeks (trial endpoint) |
| Mazdutide | Days–2 weeks | 48–60 weeks |
| Pemvidutide | Days–2 weeks | 48+ weeks |
| Cagrilintide | Days–2 weeks | 26–68 weeks (trial endpoints) |
| Pramlintide | First meal (fullness, after-meal glucose) | 16–52 weeks (weight, HbA1c) |
| CagriSema | Days–2 weeks | 68+ weeks |
| Eloralintide | Days–2 weeks | 48 weeks (phase 2 endpoint) |
| Petrelintide | Days–2 weeks | 42 weeks (phase 2, still falling) |
| Amycretin | Days–2 weeks | 36 weeks (longest trial so far) |
| VK2735 | Days–2 weeks | 78 weeks (phase 3 endpoint, not yet read out) |
| Enicepatide | Days–2 weeks | 48 weeks (phase 2 endpoint, no plateau) |
| Ecnoglutide | Days–2 weeks | 48 weeks (phase 3, no plateau) |
| Efinopegdutide | Weeks | 24–52 weeks (trial endpoints) |
| SLU-PP-332 | Unknown in people | Unknown in people |
Questions people ask
How long does ecnoglutide take to work?
Ecnoglutide’s onset is days–2 weeks, its peak effect comes at 48 weeks (phase 3, no plateau), and its typical duration is ongoing, by the library’s timeline (backed by clinical trial data).
When does ecnoglutide reach its peak effect?
By the library’s timeline, ecnoglutide’s peak effect comes at 48 weeks (phase 3, no plateau), backed by clinical trial data.
How long is ecnoglutide usually run?
The library’s timeline gives ecnoglutide’s typical duration as ongoing; its cycle note says: Used continuously, once weekly, in its trials: 40 to 48 weeks in obesity and up to 52 weeks in type 2 diabetes, with the dose doubled every 4 weeks up to the maintenance dose.
What does the library say about the first days on ecnoglutide?
Its first note on ecnoglutide, for days 1–28 (weeks 1–4), is “A low first month”, resting on randomized trials.